Trial Details
COMPLETEDBasic Information
| Clinical ID | c4309 |
|---|---|
| Identifier | NCT00724126 |
| Trial Title | Rifaximin 3 Times/Day (TID) for Non-Constipation Irritable Bowel Syndrome (IBS) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Non-Constipation Irritable Bowel Syndrome |
| Interventions | DRUG: Rifaximin|DRUG: Placebo |
Participant Information
| Sponsor | Bausch Health Americas, Inc. |
|---|---|
| City | Anniston |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2008-07 |
|---|---|
| Primary Completion Date | 2009-08 |
| Completion Date | 2009-09 |